DrugAlert provides timely medication-related advice direct to your inbox.
Scroll

DrugAlert

DrugAlert provides timely advice direct to your inbox and is based on information from drug manufacturers regarding critical changes to medication access such as the discontinuation, short supply or unavailability, recalls and other important drug-related information. See below to view the most recent volumes of DrugAlert.

Availability of Clexane® 60mg

DrugAlert Volume 936

HPS Pharmacies wishes to advise that Sanofi Australia is experiencing a supply interruption for Clexane® 60mg injection syringes as follows: Clexane® Pre-filled Syringes Enoxaparin sodium 60mg/0.6mL ARTG 56709 Normal supplies of Clexane® 60mg are…

Read more

Discontinuation of Oruvail® SR and Orudis® SR

DrugAlert Volume 935

HPS Pharmacies wishes to advise that Sanofi Pharmaceuticals are discontinuing ketoprofen capsules as follows: Oruvail® SR Capsules Ketoprofen 200mg ARTG 42422  Orudis® SR Capsules Ketoprofen 200mg ARTG 27535 Sanofi estimates that supplies of each…

Read more

Availability of Orencia®

DrugAlert Volume 934

Further to DrugAlert Volume 929, HPS Pharmacies wish to advise that Bristol-Myers Squibb is experiencing a supply interruption for Orencia® as follows: Orencia® ClickJect® Abatacept 125mg ARTG 236039  Orencia® Prefilled Syringe Abatacept 125mg ARTG…

Read more

Availability of Octreotide Ampoules

DrugAlert Volume 933

HPS Pharmacies wishes to advise that there is a supply interruption for octreotide ampoules as follows: Product ARTG Anticipated availability Octreotide GH 50 micrograms/1 mL 148404 Early March 2025* Octreotide GH 100 micrograms/1 mL…

Read more

Defect Correction and Recall Update for Panadol® Children 100mg/mL

DrugAlert Volume 932

Further to DrugAlert Volume 930, HPS Pharmacies wish to provide an update on the action required for the product defect correction and recall of Panadol® Children 1 Month – 1 Year: Panadol Children 1…

Read more

Defect Correction for Ryaltris® Nasal Spray

DrugAlert Volume 931

HPS Pharmacies wish to give notice that Seqirus Pty, in consultation with the Therapeutic Goods Administration (TGA), has issued a product defect correction for Ryaltris® nasal spray, as follows: Ryaltris Nasal Spray Olopatadine 600mcg…

Read more
Load More

August 2023

Availability of Mirena® (Aug. 01 2023)

July 2023

November 2020

February 2020

Availability of Glucose Intravenous Infusion (Feb. 26 2020)

Availability of Ephedrine Hydrochloride (Feb. 26 2020)

Availability of OsmoLax® (Feb. 26 2020)

Availability of Famotidine (Feb. 26 2020)

Availability of BenPen™ (Feb. 21 2020)

Availability of Carbimazole (Feb. 21 2020)

Availability of Calcium Gluconate Gel (Feb. 21 2020)

Availability of Pindolol (Feb. 21 2020)

Availability of Bleomycin Vials (Feb. 21 2020)

Availability of Prazosin (Feb. 20 2020)

Availability of Phenoxymethylpenicillin (Feb. 20 2020)

Availability of Dantrolene (Feb. 20 2020)

Availability of Minipress® (Feb. 20 2020)

Availability of Verapamil Tablets (Feb. 19 2020)

Availability of Carafate® Tablets (Feb. 19 2020)

Availability of Pneumovax® 23 (Feb. 18 2020)

Availability of Span-K® Tablets (Feb. 17 2020)

Availability of Irinotecan (Feb. 17 2020)

Defect correction for Palexia® SR 100mg (Feb. 14 2020)

Availability of Haemorol™ (Feb. 14 2020)

Availability of Primacin® (Feb. 14 2020)

Availability of EpiPen® Jr. (Feb. 14 2020)

Availability of Amoxicillin & Clavulanic Acid Suspension (Feb. 12 2020)

Availability of Emollient Ointment Sterile (Feb. 11 2020)

Availability of Hydroxocobalamin Ampoules (Feb. 11 2020)

Availability of Fleet® Ready-to-Use Enema (Feb. 07 2020)

Availability of Gentamicin Ampoules (Feb. 07 2020)

Availability of Hand Sanitisers (Feb. 07 2020)

Availability of Ciprofloxacin IV (Feb. 07 2020)

Availability of Zyban® SR Tablets (Feb. 06 2020)

Availability of DBL™ Rocuronium Bromide Vials (Feb. 05 2020)

Availability of Gastrogel Antacid® Oral Suspension (Feb. 05 2020)

Availability of Integrilin® (Feb. 05 2020)

Availability of Tamoxifen Tablets (Feb. 04 2020)

Availability of Ferro-Grad C® Tablets (Feb. 04 2020)

Availability of Minims® Phenylephrine Eye Drops (Feb. 04 2020)

Availability of Panadol® Suppositories (Feb. 04 2020)

Discontinuation of Zantac® Effervescent (Feb. 03 2020)